Abstract:OBJECTIVE:To investigate the clinical and immunological characteristics of overlap myositis (OM) patients.METHODS:The data of 368 patients with idiopathic inflammatory myopathies (IIMs) admitted to Peking University People's Hospital from January 2004 to August 2020 were analyzed retrospectively, including demographic characteristics, clinical characteristics (including fever, Gottron' s sign/papules, Heliotrope rash, V-sign, Shawl sign, Mechanic' s hands, skin ulceration, periungual erythema, subcutaneous calcinosis, dysphagia, myalgia, myasthenia, arthritis, Raynaud' s phenomenon, interstitial lung disease, pulmonary hypertension and myocardial involvement), laboratory characteristics, immunological characteristics [including antinuclear antibodies, rheumatoid factors, myositis-associated autoantibodies (MAAs) and myositis-specific autoantibodies (MSAs)] and survival. The clinical and immunological characteristics and prognostic differences of OM and non-OM were compared. The Kaplan-Meier and Log Rank methods were used to analyze the survival.RESULTS:A total of 368 patients were included. 23.9% (88/368) of IIMs patients were OM patients. Among the 88 OM patients, 85.2% (75/88) of them were female, and the median interval between disease onset and diagnosis was 13.5 months. The incidence of overlapped connective tissue diseases in the OM patients was dermatomyositis (DM) in 60.2%, polymyositis (PM) in 3.4%, immune-mediated necrotizing myopathy (IMNM) in 2.3% and anti-synthetase syndrome (ASS) in 34.1%. Compared with the non-OM patients, the proportion of the females in the OM patients was higher (85.2% vs. 72.1%, P=0.016), the OM patients had longer disease duration [13.5(4.5, 48.0) months vs. 4.0(2.0, 12.0) months, P < 0.001]. As for clinical characteristics, compared with the non-OM patients, the incidence of V-sign (25.0% vs. 44.6%, P=0.001) and periungual erythema (8.0% vs. 19.6%, P=0.013) were lower; the incidence of Raynaud's phenomenon (14.8% vs. 1.8%, P < 0.001), interstitial pneumonia (88.6% vs. 72.1%, P=0.001), pulmonary hypertension (22.7% vs. 7.5%, P < 0.001) and myocardial involvement (18.2% vs. 9.3%, P=0.033) were higher. As for immunological characteristics, compared with the non-OM patients, the incidence of elevated aspartate aminotransferase (AST) (31.8% vs. 45.0%, P=0.035) was lower and elevated C-reactive protein (CRP) (58.0% vs. 44.6%, P=0.037) was higher; the positive rates of antinuclear antibodies (ANA) (85.1% vs. 63.4%, P=0.001) and rheumatoid factors (RF) (40.2% vs. 17.8%, P < 0.001) and anti-Ro-52 (71.6% vs. 56.1%, P=0.038) in serum were higher. There was no significant difference in the survival between the OM patients and non-OM patients.CONCLUSION:Pulmonary hypertension and myocardial involvement were frequently observed in OM.

Patterns of recurrence in idiopathic orbital myositis

Magnetic Resonance Imaging of Idiopathic Orbital Myositis

Features Associated with Recurrence of Idiopathic Orbital Inflammatory Pseudotumor.

Treatment of Idiopathic Orbital Myositis with Frequent Relapses: First Case with Tacrolimus and Review of Literature

Clinical and Magnetic Resonance Imaging Features in Idiopathic Orbital Myositis:5 Cases Report

Orbital myositis in a patient with Crohn's disease: A case report of two episodes

Clinical heterogeneity between two subgroups of patients with idiopathic orbital inflammation

A Clinical Analysis of Idiopathic Orbital Inflammatory Pseudotumor

Analyzing histopathological aspects and cell populations in orbital inflammatory involvement in systemic diseases: A case series from the Rheumatologist's perspective

Orbital myositis in systemic lupus erythematosus: a case-based review

Differentiation of bacterial orbital cellulitis and diffuse non-specific orbital inflammation on magnetic resonance imaging

An Evidence-Based Approach to Diagnosing Patients Presenting With Orbital Inflammatory Syndromes (An American Ophthalmological Society Thesis)

The Differentiation of Idiopathic Inflammatory Pseudotumor from Lymphoid Tumors of Orbit: Analysis of 319 Cases

Cellular pattern and orbital fat involvement are possible risk factors for the failure of corticosteroids in patients with pure idiopathic orbital inflammation syndrome: lessons from the French prospective SIOI cohort study (part II)

Epidemiology of Orbital Inflammatory Disease: An AAO IRIS Registry Study

Non-infectious hypertrophic pachymeningitis associated with orbital inflammatory disease: a pooled analysis

Clinical characteristics and predictive factors of recurrent idiopathic transverse myelitis

Clinical and Immunological Characteristics of 88 Cases of Overlap Myositis

[36 Case Idiopathic Orbital Inflammatory Pseudotumor with Sinus Involvement].

Lupus erythematosus profundus masquerading as idiopathic orbital inflammatory syndrome

Idiopathic Orbital Inflammatory Pseudotumor in Chinese Children